Ameritas Investment Partners’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Ameritas Investment Partners’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,168	Closed	-$106K	–	3174
2024 Q3	$106K	Hold	3,168	–	–	﹤0.01%	1748
2024 Q2	$85.6K	Buy	3,168 +682	+27%	+$13.4K	﹤0.01%	1827
2024 Q1	$53.7K	Buy	2,486 +1,200	+93%	+$26.2K	﹤0.01%	2111
2023 Q4	$7.75K	Hold	1,286	–	–	﹤0.01%	2905
2023 Q3	$7.15K	Hold	1,286	–	–	﹤0.01%	2923
2023 Q2	$9.44K	Buy	+1,286	New	+$9.73K	﹤0.01%	2923

Ameritas Investment Partners's LBPH Position: Q4 2024 in Review

Ameritas Investment Partners sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 3,168 shares — an estimated $106K sold.

Ameritas Investment Partners first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $106K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Ameritas Investment Partners reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Ameritas Investment Partners sold 3,168 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $106K.
Ameritas Investment Partners first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Ameritas Investment Partners's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $106K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Ameritas Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.